See also this year's filing and all EDGAR filings for this company.
PDF Report 0001638833_2025_Surgery_Partners_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4641026108850736, 'aggregate_val': 2937200000, 'exp_sum': 5480900000, 'exp_to_value': {'LaborExpense': 971000000, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 118200000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 2543700000, 'DepreciationDepletionAndAmortization': 176000000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 1672000000}} |
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.4495710598238688, 'aggregate_val': 2900100000, 'exp_sum': 5268800000, 'exp_to_value': {'LaborExpense': 907500000, 'CostOfGoodsAndServicesSold': 0, 'GeneralAndAdministrativeExpense': 138700000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 2368700000, 'DepreciationDepletionAndAmortization': 152600000, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 0, 'remainder_Expenses': 1701300000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001638833, Surgery Partners Inc
| xvar | xval | |
|---|---|---|
| 0 | IntangibleAssets | 5,113,700,000 |
| 1 | AssetsNonCurrent | 353,200,000 |
| 2 | AssetsCurrent | 1,119,400,000 |
| 3 | PropertyPlantAndEquipment | 1,088,300,000 |
| 4 | remainder_Assets | 215,400,000 |
| 5 | LongTermLiabilities | 0 |
| 6 | LiabilitiesCurrent | 624,400,000 |
| 7 | remainder_Liabilities | 0 |
| 8 | LaborExpense | 907,500,000 |
| 9 | CostOfGoodsAndServicesSold | 0 |
| 10 | GeneralAndAdministrativeExpense | 138,700,000 |
| 11 | GoodwillImpairmentLoss | 0 |
| 12 | OperatingCostsAndExpenses | 2,368,700,000 |
| 13 | DepreciationDepletionAndAmortization | 152,600,000 |
| 14 | SellingAndMarketingExpense | 0 |
| 15 | ResearchAndDevelopmentExpense | 0 |
| 16 | remainder_Expenses | -667,400,000 |
| 17 | remainder_Revenues | 3,114,300,000 |
| 18 | remainder_NetIncome | -201,700,000 |
| 19 | remainder_ComprehensiveNetIncome | -233,300,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 7,890,000,000 |
| 1 | Liabilities | 624,400,000 |
| 2 | Expenses | 2,900,100,000 |
| 3 | Revenues | 3,114,300,000 |
| 4 | StockholdersEquity | 7,265,600,000 |
| 5 | NetIncome | 12,500,000 |
| 6 | ComprehensiveNetIncome | -220,800,000 |
| 7 | BaseVar | 7,481,900,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.42 |
| 9 | EconomicCapitalRatio | 2.68 |